2407 Stock Overview
Gaush Meditech Ltd., together with its subsidiaries, researches and develops, produces, and sells ophthalmic medical devices in the People’s Republic of China and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 4/6 |
| Past Performance | 3/6 |
| Financial Health | 5/6 |
| Dividends | 2/6 |
Gaush Meditech Ltd Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | HK$19.94 |
| 52 Week High | HK$49.50 |
| 52 Week Low | HK$15.20 |
| Beta | 0 |
| 1 Month Change | 4.18% |
| 3 Month Change | -44.61% |
| 1 Year Change | -56.18% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -62.13% |
Recent News & Updates
Recent updates
Shareholder Returns
| 2407 | HK Medical Equipment | HK Market | |
|---|---|---|---|
| 7D | 3.9% | 5.9% | 2.6% |
| 1Y | -56.2% | -45.4% | -7.4% |
Return vs Industry: 2407 underperformed the Hong Kong Medical Equipment industry which returned -45.4% over the past year.
Return vs Market: 2407 underperformed the Hong Kong Market which returned -7.4% over the past year.
Price Volatility
| 2407 volatility | |
|---|---|
| 2407 Average Weekly Movement | 11.1% |
| Medical Equipment Industry Average Movement | 7.0% |
| Market Average Movement | 7.4% |
| 10% most volatile stocks in HK Market | 15.0% |
| 10% least volatile stocks in HK Market | 3.6% |
Stable Share Price: 2407's share price has been volatile over the past 3 months.
Volatility Over Time: 2407's weekly volatility (11%) has been stable over the past year, but is still higher than 75% of Hong Kong stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1998 | 869 | Xinwei Liu | www.gaush.com |
Gaush Meditech Ltd., together with its subsidiaries, researches and develops, produces, and sells ophthalmic medical devices in the People’s Republic of China and internationally. The company operates through Proprietary Products, Distribution, Technical, and Others segments. Its ophthalmic medical devices are used for diagnosis, treatment, or surgeries, including vitreoretinal diseases, cataract, glaucoma, refractive surgery, ocular surface diseases, optometry, and pediatric ophthalmology.
Gaush Meditech Ltd Fundamentals Summary
| 2407 fundamental statistics | |
|---|---|
| Market cap | HK$2.95b |
| Earnings (TTM) | HK$187.34m |
| Revenue (TTM) | HK$1.52b |
16.6x
P/E Ratio2.0x
P/S RatioIs 2407 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 2407 income statement (TTM) | |
|---|---|
| Revenue | CN¥1.41b |
| Cost of Revenue | CN¥714.64m |
| Gross Profit | CN¥691.60m |
| Other Expenses | CN¥518.08m |
| Earnings | CN¥173.52m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.17 |
| Gross Margin | 49.18% |
| Net Profit Margin | 12.34% |
| Debt/Equity Ratio | 36.5% |
How did 2407 perform over the long term?
See historical performance and comparison